IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS

Mesenchymal stromal or stem cells (MSC) represent a population of primitive fibroblastlike cells that are able to differentiate into cellular lineages of connective tissue (osteocytes, chondrocytes, adipocytes), skeletal muscles, and blood vessels. The review deals with contemporary views concerning...

Full description

Bibliographic Details
Main Author: V. B. Klimovich
Format: Article
Language:Russian
Published: SPb RAACI 2014-08-01
Series:Medicinskaâ Immunologiâ
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/677
id doaj-b86856e30d5846bdb08cc4c250524e5c
record_format Article
spelling doaj-b86856e30d5846bdb08cc4c250524e5c2021-07-29T09:02:28ZrusSPb RAACIMedicinskaâ Immunologiâ1563-06252313-741X2014-08-0116210712610.15789/1563-0625-2014-2-107-126674IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLSV. B. Klimovich0Russian Research Center for Radiology and Surgical Technologies, Ministry of Health Care, St. PetersburgMesenchymal stromal or stem cells (MSC) represent a population of primitive fibroblastlike cells that are able to differentiate into cellular lineages of connective tissue (osteocytes, chondrocytes, adipocytes), skeletal muscles, and blood vessels. The review deals with contemporary views concerning descent, immunophenotype and immunogenicity of MSC. The studies over last decade revealed an ability of MSC to function as immunomodulatory populations which may suppress innate immunity factors (dendritic cells, natural killers, complement), as well as T-helpers and cytotoxic T-lymphocytes, along with activation of regulatory T lymphocytes (Treg). Special attention is given to analysis of conflicting data about influence of MSC on functions of B-lymphocytes and plasma cells in experimental settings, both in vitro and in vivo conditions. Data presently available are insufficient to explain the controversions revealed. In future investigations, it is necessary to consider attribution of B-cells to B1a, B1b, or B2 subpopulations as well as possible presence of poorly studied regulatory B-cells. It is also important also to take into account potential heterogeneity of initial MSC populations being isolated according to previously approved protocols. (Med. Immunol., 2014, vol. 16, N 2, pp 107-126)https://www.mimmun.ru/mimmun/article/view/677mesenchymal stem cellsimmunomodulationcellular therapy
collection DOAJ
language Russian
format Article
sources DOAJ
author V. B. Klimovich
spellingShingle V. B. Klimovich
IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
Medicinskaâ Immunologiâ
mesenchymal stem cells
immunomodulation
cellular therapy
author_facet V. B. Klimovich
author_sort V. B. Klimovich
title IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
title_short IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
title_full IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
title_fullStr IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
title_full_unstemmed IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
title_sort immunomodulatory activity of mesenchimal stromal (stem) cells
publisher SPb RAACI
series Medicinskaâ Immunologiâ
issn 1563-0625
2313-741X
publishDate 2014-08-01
description Mesenchymal stromal or stem cells (MSC) represent a population of primitive fibroblastlike cells that are able to differentiate into cellular lineages of connective tissue (osteocytes, chondrocytes, adipocytes), skeletal muscles, and blood vessels. The review deals with contemporary views concerning descent, immunophenotype and immunogenicity of MSC. The studies over last decade revealed an ability of MSC to function as immunomodulatory populations which may suppress innate immunity factors (dendritic cells, natural killers, complement), as well as T-helpers and cytotoxic T-lymphocytes, along with activation of regulatory T lymphocytes (Treg). Special attention is given to analysis of conflicting data about influence of MSC on functions of B-lymphocytes and plasma cells in experimental settings, both in vitro and in vivo conditions. Data presently available are insufficient to explain the controversions revealed. In future investigations, it is necessary to consider attribution of B-cells to B1a, B1b, or B2 subpopulations as well as possible presence of poorly studied regulatory B-cells. It is also important also to take into account potential heterogeneity of initial MSC populations being isolated according to previously approved protocols. (Med. Immunol., 2014, vol. 16, N 2, pp 107-126)
topic mesenchymal stem cells
immunomodulation
cellular therapy
url https://www.mimmun.ru/mimmun/article/view/677
work_keys_str_mv AT vbklimovich immunomodulatoryactivityofmesenchimalstromalstemcells
_version_ 1721249880311070720